药品注册申请号:088627
申请类型:ANDA (仿制药申请)
申请人:TEVA
申请人全名:TEVA PHARMACEUTICALS USA INC
产品信息
产品号商品名活性成分剂型/给药途径规格/剂量参比药物(RLD)生物等效参考标准(RS)治疗等效代码该申请号批准日期该产品号批准日期市场状态
001 ACETAMINOPHEN AND CODEINE PHOSPHATE ACETAMINOPHEN; CODEINE PHOSPHATE TABLET;ORAL 300MG;15MG No No AA 1985/03/06 1985/03/06 Prescription
批准历史,通知信,药品说明书,综述等审批信息
批准日期申请类型申请提交号审查批准结论申请内容分类审评分类(优先审评;罕用药状态)通知信、综述、标签、说明书备注
2019/10/09 SUPPL 62 Approval Labeling STANDARD
2018/09/21 SUPPL 61 Approval Labeling STANDARD
2018/09/18 SUPPL 60 Approval REMS
2017/08/29 SUPPL 58 Approval Labeling STANDARD
2016/12/16 SUPPL 57 Approval Labeling STANDARD
2016/12/16 SUPPL 56 Approval Labeling STANDARD
2013/10/18 SUPPL 53 Approval Labeling STANDARD
2013/05/10 SUPPL 51 Approval Labeling STANDARD
2011/06/22 SUPPL 48 Approval Labeling
2008/07/18 SUPPL 45 Approval Labeling
2008/01/07 SUPPL 44 Approval Labeling
2000/07/07 SUPPL 40 Approval Manufacturing (CMC)
1999/03/03 SUPPL 39 Approval Manufacturing (CMC)
1998/03/09 SUPPL 38 Approval Manufacturing (CMC)
1998/03/09 SUPPL 36 Approval Manufacturing (CMC)
1997/12/04 SUPPL 34 Approval Manufacturing (CMC)
1997/05/06 SUPPL 35 Approval Manufacturing (CMC)
1996/11/27 SUPPL 33 Approval Manufacturing (CMC)
1996/08/16 SUPPL 32 Approval Manufacturing (CMC)
1995/10/20 SUPPL 31 Approval Manufacturing (CMC)
1995/10/03 SUPPL 30 Approval Manufacturing (CMC)
1995/10/03 SUPPL 29 Approval Manufacturing (CMC)
1995/10/03 SUPPL 28 Approval Manufacturing (CMC)
1995/03/02 SUPPL 26 Approval Manufacturing (CMC)
1995/01/27 SUPPL 27 Approval Labeling
1994/07/05 SUPPL 12 Approval Manufacturing (CMC)
1994/01/26 SUPPL 25 Approval Manufacturing (CMC)
1994/01/26 SUPPL 24 Approval Manufacturing (CMC)
1994/01/26 SUPPL 23 Approval Manufacturing (CMC)
1994/01/26 SUPPL 22 Approval Manufacturing (CMC)
1994/01/26 SUPPL 21 Approval Manufacturing (CMC)
1994/01/26 SUPPL 20 Approval Manufacturing (CMC)
1993/09/22 SUPPL 19 Approval Manufacturing (CMC)
1993/05/25 SUPPL 15 Approval Manufacturing (CMC)
1993/05/25 SUPPL 14 Approval Manufacturing (CMC)
1993/04/01 SUPPL 17 Approval Manufacturing (CMC)
1993/04/01 SUPPL 16 Approval Manufacturing (CMC)
1993/04/01 SUPPL 13 Approval Manufacturing (CMC)
1993/02/04 SUPPL 18 Approval Labeling
1992/12/30 SUPPL 11 Approval Manufacturing (CMC)
1990/01/11 SUPPL 10 Approval Labeling
1988/04/08 SUPPL 8 Approval Labeling
1986/10/10 SUPPL 3 Approval Manufacturing (CMC)
1986/10/10 SUPPL 2 Approval Manufacturing (CMC)
1986/10/10 SUPPL 1 Approval Manufacturing (CMC)
1985/03/06 ORIG 1 Approval
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号专利号专利过期日是否物质专利是否产品专利专利用途代码撤销请求提交日期专利下载备注
与本品相关的市场独占权保护信息
关联产品号独占权代码失效日期备注
与本品治疗等效的药品
活性成分:ACETAMINOPHEN; CODEINE PHOSPHATE 剂型/给药途径:TABLET;ORAL 规格:300MG;15MG 治疗等效代码:AA
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
088627 001 ANDA ACETAMINOPHEN AND CODEINE PHOSPHATE ACETAMINOPHEN; CODEINE PHOSPHATE TABLET;ORAL 300MG;15MG Prescription No No AA 1985/03/06 TEVA
089990 001 ANDA ACETAMINOPHEN AND CODEINE PHOSPHATE ACETAMINOPHEN; CODEINE PHOSPHATE TABLET;ORAL 300MG;15MG Prescription No No AA 1988/09/30 VINTAGE
040419 001 ANDA ACETAMINOPHEN AND CODEINE PHOSPHATE ACETAMINOPHEN; CODEINE PHOSPHATE TABLET;ORAL 300MG;15MG Prescription No Yes AA 2001/05/31 SPECGX LLC
202800 001 ANDA ACETAMINOPHEN AND CODEINE PHOSPHATE ACETAMINOPHEN; CODEINE PHOSPHATE TABLET;ORAL 300MG;15MG Prescription No No AA 2013/04/15 AUROLIFE PHARMA LLC
211610 001 ANDA ACETAMINOPHEN AND CODEINE PHOSPHATE ACETAMINOPHEN; CODEINE PHOSPHATE TABLET;ORAL 300MG;15MG Prescription No No AA 2019/06/27 EYWA
212418 001 ANDA ACETAMINOPHEN AND CODEINE PHOSPHATE ACETAMINOPHEN; CODEINE PHOSPHATE TABLET;ORAL 300MG;15MG Prescription No No AA 2019/09/10 ELITE LABS INC
更多信息
药品NDC数据与药品包装、标签说明书
©2006-2020 DrugFuture->U.S. FDA Drugs Database